Jai N Patel

Jai N Patel

UNVERIFIED PROFILE

Are you Jai N Patel?   Register this Author

Register author
Jai N Patel

Jai N Patel

Publications by authors named "Jai N Patel"

Are you Jai N Patel?   Register this Author

28Publications

438Reads

23Profile Views

Drug Prescribing and Outcomes After Pharmacogenomic Testing in a Developmental and Behavioral Health Pediatric Clinic.

J Dev Behav Pediatr 2020 Jan;41(1):65-70

Developmental and Behavioral Pediatrics of the Carolinas, Atrium Health, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DBP.0000000000000746DOI Listing
January 2020

Clarity Also Needed for Direct-to-Consumer Pharmacogenetic Tests.

J Clin Oncol 2020 Jan 21;38(3):283-284. Epub 2019 Nov 21.

Jai N. Patel, PharmD, Atrium Health, Charlotte, NC; and Howard L. McLeod, PharmD, Moffitt Cancer Center, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01917DOI Listing
January 2020

Acupuncture for Cancer Pain and Symptom Management in a Palliative Medicine Clinic.

Am J Hosp Palliat Care 2019 Apr 4;36(4):326-332. Epub 2018 Oct 4.

2 Section of Palliative Medicine, Department of Supportive Oncology, Atrium Health, Charlotte, NC, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1049909118804464
Publisher Site
http://dx.doi.org/10.1177/1049909118804464DOI Listing
April 2019

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

N Engl J Med 2019 02;380(8):720-728

From the Department of Hematology and Medical Oncology, Taussig Cancer Institute and Case Comprehensive Cancer Center, Cleveland Clinic, Cleveland (A.A.K.); the Department of Medicine, Memorial Sloan Kettering Cancer Center (G.A.S., E.M.O.), and Weill Cornell Medical College (G.A.S., E.M.O.), New York; the Thrombosis Research Institute and University College London, London (A.K.K.); University of Texas M.D. Anderson Cancer Center, Houston (S.V.-R.), and U.S. Oncology Research-Texas Oncology, Tyler (H.A.Y.) - both in Texas; the Department of Medicine, Charité Universitätsmedizin Berlin, Berlin (H.R.); the Division of Hematology-Oncology, University of California Davis School of Medicine, Sacramento (T.W.), and the Keck School of Medicine, University of Southern California, Los Angeles (H.A.L.); the Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore (M.B.S.); the University of Washington School of Medicine (D.A.G., N.M.K., G.H.L.), Advanced Cancer Research Group (N.M.K.), and Fred Hutchinson Cancer Research Center (G.H.L.), Seattle; Penn State Cancer Institute, Milton S. Hershey Medical Center, Hershey, PA (C.P.B.); the Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, NC (J.N.P.); Janssen Scientific Affairs, Titusville (P.W., P.B., S.K.), and Janssen Research and Development, Raritan (U.V.) - both in New Jersey; the Department of Medicine, McMaster University, Hamilton, ON, Canada (J.E.); the Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN (R.M.); and the Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston (K.A.B.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1814630
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1814630DOI Listing
February 2019

A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.

J Oncol Pharm Pract 2019 Jan 27;25(1):179-186. Epub 2017 Oct 27.

3 Bone Marrow Transplantation, Wake Forest Baptist Medical Center, Winston-Salem, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155217738324DOI Listing
January 2019

Colorectal Cancer Biomarkers in the Era of Personalized Medicine.

J Pers Med 2019 Jan 14;9(1). Epub 2019 Jan 14.

Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jpm9010003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463111PMC
January 2019

Personalizing aromatase inhibitor therapy in patients with breast cancer.

Cancer Treat Rev 2018 Nov 23;70:47-55. Epub 2018 Jul 23.

Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.07.014DOI Listing
November 2018

Value of Supportive Care Pharmacogenomics in Oncology Practice.

Oncologist 2018 08 5;23(8):956-964. Epub 2018 Apr 5.

The DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2017-0599DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156181PMC
August 2018

Genetic Effects on Hematopoietic Stem Cell Transplant Prognosis and Outcomes: More Than Just Histocompatibility.

Biol Blood Marrow Transplant 2017 08 8;23(8):1227-1228. Epub 2017 Jun 8.

Department of Hematologic Oncology and Blood Disorders, Hematologic Oncology Translational Research Laboratory, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791173049
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2017.05.029DOI Listing
August 2017

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives.

Authors:
Jai N Patel

Pharmgenomics Pers Med 2016 12;9:65-77. Epub 2016 Jul 12.

Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

View Article

Download full-text PDF

Source
https://www.dovepress.com/cancer-pharmacogenomics-challenges
Publisher Site
http://dx.doi.org/10.2147/PGPM.S62918DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948716PMC
July 2016

Biological role and clinical implications of homeobox genes in serous epithelial ovarian cancer.

Gynecol Oncol 2016 06 21;141(3):608-615. Epub 2016 Mar 21.

Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.03.004DOI Listing
June 2016

Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.

Pharmacogenomics 2016 Mar 12;17(4):417-34. Epub 2016 Feb 12.

University of North Carolina Eshelman School of Pharmacy, CB #7355, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/pgs.15.178
Publisher Site
http://dx.doi.org/10.2217/pgs.15.178DOI Listing
March 2016

Personalizing chemotherapy dosing using pharmacological methods.

Cancer Chemother Pharmacol 2015 Nov 23;76(5):879-96. Epub 2015 Aug 23.

Hygeia Hospital, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2849-xDOI Listing
November 2015

Lung cancer biomarkers, targeted therapies and clinical assays.

Transl Lung Cancer Res 2015 Oct;4(5):503-14

Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.06.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630522PMC
October 2015

Cancer pharmacogenomics: implications on ethnic diversity and drug response.

Authors:
Jai N Patel

Pharmacogenet Genomics 2015 May;25(5):223-30

Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000134DOI Listing
May 2015

A community-based multicenter trial of pharmacokinetically guided 5-fluorouracil dosing for personalized colorectal cancer therapy.

Oncologist 2014 Sep 12;19(9):959-65. Epub 2014 Aug 12.

Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, USA; Eshelman School of Pharmacy, Institute for Pharmacogenomics and Individualized Therapy, and Biostatistics Core, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA; Indiana University Simon Cancer Center, Indianapolis, Indiana, USA; Cone Health Cancer Center, Greensboro, North Carolina, USA; Rex Healthcare, Raleigh, North Carolina, USA; Leo W. Jenkins Cancer Center, Greenville, North Carolina, USA; Marion L. Shepard Cancer Center, Washington, North Carolina, USA; Cancer Care of Western North Carolina, Asheville, North Carolina, USA; Moffitt Cancer Center, Tampa, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153454PMC
September 2014

Clinically relevant cancer biomarkers and pharmacogenetic assays.

J Oncol Pharm Pract 2014 Feb 24;20(1):65-72. Epub 2013 Jan 24.

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA; UNC Institute for Pharmacogenomics and Individualized Therapy, UNC Eshelman School of Pharmacy, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155212473862DOI Listing
February 2014

Application of genotype-guided cancer therapy in solid tumors.

Authors:
Jai N Patel

Pharmacogenomics 2014 Jan;15(1):79-93

Department of Clinical Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, 1021 Morehead Medical Drive, Charlotte, NC 28203, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/pgs.13.227
Publisher Site
http://dx.doi.org/10.2217/pgs.13.227DOI Listing
January 2014

Implications of genome-wide association studies in cancer therapeutics.

Br J Clin Pharmacol 2013 Sep;76(3):370-80

UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, NC, 27599-7361, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769665PMC
September 2013

Gastric cancer pharmacogenetics: progress or old tripe?

Pharmacogenomics 2013 Jul;14(9):1053-64

UNC Institute for Pharmacogenomics & Individualized Therapy, University of North Carolina, Chapel Hill, NC 27599-7361, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.13.88DOI Listing
July 2013

Sylatron: a pegylated interferon for use in melanoma.

Ann Pharmacother 2012 Jun 22;46(6):830-8. Epub 2012 May 22.

Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1345/aph.1Q791
Publisher Site
http://dx.doi.org/10.1345/aph.1Q791DOI Listing
June 2012